Technology Targeting TGFβ Signaling for Enhancing Cancer Radiotherapy and Immunotherapy Efficacy The method leverages a negative regulator to inhibit TGFβ signaling in myeloid cells, potentially enhancing the efficacy of radiotherapy and immunotherapy in cancer treatment by reducing immune suppression. The problem:…
Program Past VCIC Participants 2026 Monarch Fund won the regional Venture Capital Investment Competition. Team members included Angela Huang, Kim Berg, Nick Thomas, Patrick Mispireta, Leah Sidell, and Joe Wang. 2025 First Pick Ventures…
Technology Senescent Epithelial Cell Targeting and Microbiota Therapy for IBD Improved inflammatory bowel disease (IBD) management by identifying and therapeutically targeting senescent colonic epithelial cells, thereby reducing mucosal inflammation through depletion of these pro-inflammatory cells The Unmet Need: Insufficient therapeutic targeting…
